World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
24812
World Ranking
17970
National Ranking
672

Ronald R. de Krijger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ronald R. de Krijger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 400 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ronald R. de Krijger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald R. de Krijger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ronald R. de Krijger is affiliated with Erasmus University Rotterdam in the Netherlands. Their research portfolio spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research, and Endocrinology, Diabetes and Metabolism. This multidisciplinary scope supports varied investigations primarily centered on cancer biology and endocrine pathology.

The scientist's recent papers reflect a strong engagement with adrenal and paraganglionic tumors, cancer genomics, diagnostics, and pediatric oncology. Notable recent publications include:

  • "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up" (2020, Annals of Oncology)
  • "Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas" (2022, Endocrine Pathology)
  • "An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity" (2020, Nature Communications)
  • "Overview of the 2022 WHO Classification of Adrenal Cortical Tumors" (2022, Endocrine Pathology)
  • "Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin" (2021, Nature Genetics)

Frequent co-authors contributing to collaborative work with Ronald R. de Krijger include Marry M. van den Heuvel-Eibrink, Annelies M. C. Mavinkurve-Groothuis, Jarno Drost, Annemieke S. Littooij, and Godelieve A.M. Tytgat. These collaborations reflect strong interdisciplinary and interinstitutional research networks, particularly in pediatric and oncological contexts.

The scientist has published extensively in several journals and platforms. Their most common publication venues are:

  • Cancers (16 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (9 publications)
  • Endocrine Pathology (6 publications)
  • Nature Communications (5 publications)
  • Nature Reviews Endocrinology (4 publications)

Main topics in their research emphasize:

  • Renal and related cancers
  • Renal cell carcinoma treatment
  • Neuroblastoma Research and Treatments
  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Hormonal Regulation and Hypertension
  • Cancer Genomics and Diagnostics

In addition to peer-reviewed articles, Ronald R. de Krijger has contributed to book publications, including the recent title Tumors of the Adrenal Glands and Extra-Adrenal Paraganglia, published in 2024 by American Registry of Pathology Arlington, Virginia eBooks.

Best Publications

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    Martin Fassnacht;Olaf M. Dekkers;Olaf M. Dekkers;Tobias Else;Eric Baudin;Eric Baudin

  • An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

    Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek

  • Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

    Katherine A. Janeway;Su Young Kim;Maya Lodish;Vânia Nosé

  • Integrated genomic characterization of adrenocortical carcinoma

    Guillaume Assié;Eric Letouzé;Martin Fassnacht;Anne Jouinot

  • Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

    Lauren Fishbein;Lauren Fishbein;Ignaty Leshchiner;Ignaty Leshchiner;Vonn Walter;Vonn Walter;Ludmila Danilova;Ludmila Danilova

  • TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

    Guido Rindi;M Falconi;C Klersy;L Albarello

  • Malignant pheochromocytoma: Current status and initiatives for future progress

    Graeme Eisenhofer;Stefan R. Bornstein;Frederieke M. Brouwers;Nai Kong V. Cheung

  • [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

    Erwin van der Harst;Wouter W. de Herder;Hajo A. Bruining;H. Jaap Bonjer

  • MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

    Nelly Burnichon;Alberto Cascón;Francesca Schiavi;Nicole Paes Morales

  • Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells

    Friedemann Honecker;Friedemann Honecker;Hans Stoop;Ronald R. De Krijger;Yun-Fai Chris Lau

  • Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection

    Felix Beuschlein;Jens Weigel;Wolfgang Saeger;Matthias Kroiss

  • SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

    Jean Pierre Bayley;Henricus P.M. Kunst;Alberto Cascon;Maria Lourdes Sampietro

  • SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

    Esther Korpershoek;Judith Favier;Judith Favier;José Gaal;Nelly Burnichon;Nelly Burnichon

  • Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    M. Fassnacht;G. Assie;E. Baudin;G. Eisenhofer

  • Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.

    Birgit Görtz;Jürgen Roth;Akiko Krähenmann;Ronald R. de Krijger

  • EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.

    David Taïeb;Henri J. Timmers;Elif Hindié;Benjamin A. Guillet

  • Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.

    Xiaoqian Ma;Angelique C. Ziel-van der Made;Binha Autar;Hetty A. van der Korput

  • SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors

    José Gaal;Constantine A Stratakis;J Aidan Carney;Evan R Ball

  • SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

    Thomas G. Papathomas;Lindsey Oudijk;Alexandre Persu;Anthony J. Gill

Frequent Co-Authors

Wouter W. de Herder
Wouter W. de Herder Erasmus University Rotterdam
Karel Pacak
Karel Pacak National Institutes of Health
Dick Tibboel
Dick Tibboel Erasmus University Rotterdam
Steven W. J. Lamberts
Steven W. J. Lamberts Erasmus University Rotterdam
Leo J. Hofland
Leo J. Hofland Erasmus University Rotterdam
Felix Beuschlein
Felix Beuschlein University of Zurich
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité
Massimo Mannelli
Massimo Mannelli University of Florence
Annelies de Klein
Annelies de Klein Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA can lead to diverse career opportunities beyond the traditional physician pathway. Many students pursue roles in hospital management, public health, or specialized care. For those interested in leadership and administration, the best online healthcare administration degree options provide a flexible path to managing healthcare systems.

Nursing professionals looking to advance their careers may consider rn to np bridge programs to become nurse practitioners through streamlined, online study models. For those passionate about preventive health, a nutrition degree online offers foundational knowledge for careers in wellness, health education, or clinical nutrition.

Additionally, pursuing an advanced degree through one of the best online mha programs can open doors to executive roles within healthcare organizations. Each of these online academic pathways provides flexible learning solutions tailored to help you meet your professional and personal goals in the evolving healthcare landscape.

Best Scientists Citing Ronald R. de Krijger

Trending Scientists

Recently Published Articles